Yahoo Search Busca da Web

Resultado da Busca

  1. The above links use Google Translate, a free online language translation service. Computerized translations are only an approximation of the website's original content.

  2. 29 de jan. de 2014 · Case Summary. On 01/29/2014 Idenix Pharmaceuticals Inc filed an Intellectual Property - Patent lawsuit against Gilead Pharmasset LLC. This case was filed in U.S. District Courts, Delaware District. The Judge overseeing this case is Judge Leonard P. Stark. The case status is Pending - Other Pending.

  3. Responses of Leonard P. Stark Nominee to be United States District Judge for the District of Delaware to the Written Questions of Senator Jeff Sessions. 1. In your questionnaire, you indicated that you taught Constitutional Law to undergraduates at the University of Delaware in 1998 and 1999, and you included a syllabus from your Fall 1998 class.

  4. Following years of litigation, Chief Judge Stark held a two-week jury trial in December 2016. Gilead stipulated to infringement under the district court’s claim construction but argued that the ’597 was invalid patent for failure to meet the written description and enablement requirements. The jury found for Idenix, upholding the

  5. cle.cobar.org › cvweb › cgi-binLeonard Stark CLE

    Hon. Leonard P. Stark is Chief Judge of the U.S. District Court for the District of Delaware. He has been a District Judge since 2010 and for the previous three years was a Magistrate Judge on the same Court.

  6. 1 de jun. de 1996 · Amazon.com: Choosing a Leader: Party Leadership Contests in Britain from Macmillan to Blair: 9780333639283: Leonard P. Stark: Books

    • Hardcover
    • Leonard P. Stark
  7. Judges. Stark, Leonard Philip. Born 1969 in Detroit, MI Federal Judicial Service: Judge, U.S. District Court for the District of Delaware Nominated by Barack Obama on March 17, 2010, to a seat vacated by Kent A. Jordan. Confirmed by the Senate on August 5, 2010, and received commission on August 10, 2010. Served as chief judge, 2014-2021.